Medication Use Reported by Individuals With Tinnitus Who Are Seeking Internet-Based Psychological InterventionsShow others and affiliations
2021 (English)In: American Journal of Audiology, ISSN 1059-0889, E-ISSN 1558-9137, Vol. 30, no 4, p. 1088-1095Article in journal (Refereed) Published
Abstract [en]
Purpose: This study examined medication use by individuals with tinnitus who were seeking help for their tinnitus by means of a psychological intervention. Method: This study used a cross-sectional survey design and included individuals with tinnitus enrolled in an Internet-based cognitive behavioral therapy trial (n = 439). Study participants provided demographic details, completed various structured questionnaires and provided details about the medications used. The self-reported medications were classified using the United States Phamiacopeial Medicare Model Guidelines v7.0. Results: Current medication use was reported by 67% (n = 293) of the study participants. Those currently using medication were older; had consulted their primary care physician, had greater tinnitus severity, depression, anxiety, and insomnia when compared with those not reporting any current medication use. The top 10 medication used included cardiovascular agents (n = 162; 55.3%), antidepressants (n = 80; 27.3%), electrolytes/minerals/metals/vitamins (n = 70; 23.9%), respiratory tract/pulmonary agents (n = 62; 21.2%), anxiolytics (n = 59; 20.1%), hormonal agents/stimulant/replacement/modifying (thyroid; n = 45; 15.4%), gastrointestinal agents (n = 43; 14.7%), analgesics (n = 33; 11.3%), blood glucose regulators (n = 32; 10.9%), and anticonvulsants (n = 26; 8.87%). Some associations between type of medication used and demographic or tinnitus-related variables were noted especially for the cardiovascular agents, electrolytes/minerals/metals/vitamins, and anxiolytics. Conclusions: This exploratory study indicated a large percentage of patients using medication and a range of medications. Further studies are required to assess the effects of such medications on the tinnitus percept and concurrent medication moderate treatment effects.
Place, publisher, year, edition, pages
AMER SPEECH-LANGUAGE-HEARING ASSOC , 2021. Vol. 30, no 4, p. 1088-1095
National Category
Applied Psychology
Identifiers
URN: urn:nbn:se:liu:diva-183458DOI: 10.1044/2021_AJA-21-00062ISI: 000755773500014PubMedID: 34706212OAI: oai:DiVA.org:liu-183458DiVA, id: diva2:1642809
Note
Funding Agencies|National Institute on Deafness and Communication Disorders of the National Institute of Health [R21DC017214]
2022-03-082022-03-082022-05-23